Page last updated: 2024-10-24

chlorambucil and Parasitemia

chlorambucil has been researched along with Parasitemia in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Parasitemia: The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carvalhaes, MS1
Santana, JM1
Nóbrega, OT1
Aragão, JB1
Gréllier, P1
Schrével, J1
Teixeira, AR1

Other Studies

1 other study available for chlorambucil and Parasitemia

ArticleYear
Chemotherapy of an experimental Trypanosoma cruzi infection with specific immunoglobulin-chlorambucil conjugate.
    Laboratory investigation; a journal of technical methods and pathology, 1998, Volume: 78, Issue:6

    Topics: Animals; Cell Membrane; Chagas Disease; Chlorambucil; Immunoconjugates; Immunoglobulin G; Mice; Mice

1998